Ginkgo Bioworks Holdings Shares Outstanding 2020-2023 | DNA
Ginkgo Bioworks Holdings shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ginkgo Bioworks Holdings Annual Shares Outstanding
(Millions of Shares) |
| 2022 |
1,680 |
| 2021 |
1,360 |
| 2020 |
1,275 |
| 2019 |
1,149 |
Ginkgo Bioworks Holdings Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-03-31 |
1,917 |
| 2022-12-31 |
1,680 |
| 2022-09-30 |
1,631 |
| 2022-06-30 |
1,621 |
| 2022-03-31 |
1,608 |
| 2021-12-31 |
1,360 |
| 2021-09-30 |
1,324 |
| 2021-06-30 |
1,293 |
| 2021-03-31 |
1,290 |
| 2020-12-31 |
|
| 2020-09-30 |
1,287 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
